wakamoto pharm co ltd (4512:Tokyo)
wakamoto pharm co ltd (4512) Snapshot
|
Open
¥314.00
|
Previous Close
¥314.00
|
|
|
Day High
¥314.00
|
Day Low
¥308.00
|
|
|
52 Week High
03/11/13 - ¥372.00
|
52 Week Low
06/4/12 - ¥161.00
|
|
|
Market Cap
10.8B
|
Average Volume 10 Days
36.6K
|
|
|
EPS TTM
¥-6.38
|
Shares Outstanding
34.8M
|
|
|
EX-Date
03/27/13
|
P/E TM
--
|
|
|
Dividend
--
|
Dividend Yield
--
|
Related News
wakamoto pharm co ltd (4512) Related Businessweek News
No Related Businessweek News Foundwakamoto pharm co ltd (4512) Details
Wakamoto Pharmaceutical Co., Ltd. engages in the manufacture and sale of ethical drugs and non-prescription drugs. Its products include Strong Wakamoto, a gastrointestinal drug for digestion, controlling intestinal function, and nutritional supply. The company was formerly known as Society for Nutrition and Raising Children Co., Ltd. and changed its name to Wakamoto Pharmaceutical Co., Ltd. in July 1943. Wakamoto Pharmaceutical Co., Ltd. was founded in 1929 and is headquartered in Tokyo, Japan.
wakamoto pharm co ltd (4512) Key Developments
Wakamoto Pharmaceutical Co., Ltd. announced that they will report fiscal year 2013 results on May 15, 2013
Wakamoto Pharmaceutical Co., Ltd. announced that they will report Q3, 2013 results on Jan 31, 2013
Wakamoto Pharmaceutical Co., Ltd. announced that they will report Q2, 2013 results on Nov 02, 2012
| Recently Viewed | |||
| 4512:JP | ¥311.00 JPY | -3.00 |  |
| Company | Last | Change | |
| No competitor information is available for 4512. | |||
| View Industry Companies | |||
Industry Analysis
4512
Industry Average
| Valuation | 4512 | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 0.9x |
|
| Price/Book | 0.7x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 0.6x |
|
Post a JobJobs
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
- Northglenn, CO | Office DepotPosted: Mar 01
Sponsored Financial Commentaries
Sponsored Links
To contact WAKAMOTO PHARM CO LTD, please visit www.wakamoto-pharm.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
